NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) to Report Full Year 2025 Financial Results and Provide a Corporate Update on March 24, 2026

Go back to NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) to Report Full Year 2025 Financial Results and Provide a Corporate Update on March 24, 2026
(NASDAQ: NRXP) Delayed: 3.90 -0.07 (1.76%)
Previous Close $3.97    52 Week High
Open $3.99    52 Week Low
Day High $4.17    P/E N/A 
Day Low $3.83    EPS
Volume 713,081